Literature DB >> 33760889

Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry.

Wenlin Ren1, Yunkai Zhu2, Yuyan Wang2, Hongyang Shi3,4, Yin Yu2, Gaowei Hu2, Fei Feng2, Xiaomin Zhao1, Jun Lan5, Jianping Wu6,7, Devin J Kenney8, Florian Douam8, Yimin Tong3, Jin Zhong3, Youhua Xie2, Xinquan Wang5,9, Zhenghong Yuan2, Dongming Zhou10, Rong Zhang2, Qiang Ding1,9.   

Abstract

Coronavirus interaction with its viral receptor is a primary genetic determinant of host range and tissue tropism. SARS-CoV-2 utilizes ACE2 as the receptor to enter host cell in a species-specific manner. We and others have previously shown that ACE2 orthologs from New World monkey, koala and mouse cannot interact with SARS-CoV-2 to mediate viral entry, and this defect can be restored by humanization of the restrictive residues in New World monkey ACE2. To better understand the genetic determinants behind the ability of ACE2 orthologs to support viral entry, we compared koala and mouse ACE2 sequences with that of human and identified the key residues in koala and mouse ACE2 that restrict viral receptor activity. Humanization of these critical residues rendered both koala and mouse ACE2 capable of binding the spike protein and facilitating viral entry. Our study shed more lights into the genetic determinants of ACE2 as the functional receptor of SARS-CoV-2, which facilitates our understanding of viral entry.

Entities:  

Year:  2021        PMID: 33760889      PMCID: PMC7990223          DOI: 10.1371/journal.ppat.1009392

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  39 in total

Review 1.  Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Authors:  Wenhui Li; Swee-Kee Wong; Fang Li; Jens H Kuhn; I-Chueh Huang; Hyeryun Choe; Michael Farzan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.

Authors:  Fang Li
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

3.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

4.  Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.

Authors:  Jun Lan; Jiwan Ge; Jinfang Yu; Sisi Shan; Huan Zhou; Shilong Fan; Qi Zhang; Xuanling Shi; Qisheng Wang; Linqi Zhang; Xinquan Wang
Journal:  Nature       Date:  2020-03-30       Impact factor: 49.962

5.  Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.

Authors:  Wenhui Li; Chengsheng Zhang; Jianhua Sui; Jens H Kuhn; Michael J Moore; Shiwen Luo; Swee-Kee Wong; I-Chueh Huang; Keming Xu; Natalya Vasilieva; Akikazu Murakami; Yaqing He; Wayne A Marasco; Yi Guan; Hyeryun Choe; Michael Farzan
Journal:  EMBO J       Date:  2005-03-24       Impact factor: 11.598

6.  Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.

Authors:  Joana Damas; Graham M Hughes; Kathleen C Keough; Corrie A Painter; Nicole S Persky; Marco Corbo; Michael Hiller; Klaus-Peter Koepfli; Andreas R Pfenning; Huabin Zhao; Diane P Genereux; Ross Swofford; Katherine S Pollard; Oliver A Ryder; Martin T Nweeia; Kerstin Lindblad-Toh; Emma C Teeling; Elinor K Karlsson; Harris A Lewin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-21       Impact factor: 11.205

7.  The Challenges of Vaccine Development against a New Virus during a Pandemic.

Authors:  Michael S Diamond; Theodore C Pierson
Journal:  Cell Host Microbe       Date:  2020-05-13       Impact factor: 21.023

8.  Structural basis of receptor recognition by SARS-CoV-2.

Authors:  Jian Shang; Gang Ye; Ke Shi; Yushun Wan; Chuming Luo; Hideki Aihara; Qibin Geng; Ashley Auerbach; Fang Li
Journal:  Nature       Date:  2020-03-30       Impact factor: 49.962

9.  Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

Authors:  Daniel Blanco-Melo; Benjamin E Nilsson-Payant; Wen-Chun Liu; Skyler Uhl; Daisy Hoagland; Rasmus Møller; Tristan X Jordan; Kohei Oishi; Maryline Panis; David Sachs; Taia T Wang; Robert E Schwartz; Jean K Lim; Randy A Albrecht; Benjamin R tenOever
Journal:  Cell       Date:  2020-05-15       Impact factor: 41.582

10.  Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.

Authors:  Bas B Oude Munnink; Reina S Sikkema; David F Nieuwenhuijse; Robert Jan Molenaar; Emmanuelle Munger; Richard Molenkamp; Arco van der Spek; Paulien Tolsma; Ariene Rietveld; Miranda Brouwer; Noortje Bouwmeester-Vincken; Frank Harders; Renate Hakze-van der Honing; Marjolein C A Wegdam-Blans; Ruth J Bouwstra; Corine GeurtsvanKessel; Annemiek A van der Eijk; Francisca C Velkers; Lidwien A M Smit; Arjan Stegeman; Wim H M van der Poel; Marion P G Koopmans
Journal:  Science       Date:  2020-11-10       Impact factor: 47.728

View more
  11 in total

1.  Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y.

Authors:  Yichao Zhu; Wenzhao Zhou; Zubiao Niu; Jiayi Sun; Zhengrong Zhang; Qinqin Li; You Zheng; Chenxi Wang; Lihua Gao; Qiang Sun
Journal:  Biol Direct       Date:  2022-06-05       Impact factor: 7.173

2.  SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.

Authors:  John Lok Man Law; Michael Logan; Michael A Joyce; Abdolamir Landi; Darren Hockman; Kevin Crawford; Janelle Johnson; Gerald LaChance; Holly A Saffran; Justin Shields; Eve Hobart; Raelynn Brassard; Elena Arutyunova; Kanti Pabbaraju; Matthew Croxen; Graham Tipples; M Joanne Lemieux; D Lorne Tyrrell; Michael Houghton
Journal:  Vaccine       Date:  2021-08-26       Impact factor: 3.641

Review 3.  Expression pattern and function of SARS-CoV-2 receptor ACE2.

Authors:  Ruiting Li; Chengfeng Qin
Journal:  Biosaf Health       Date:  2021-08-27

4.  Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.

Authors:  Wenlin Ren; Yunkai Zhu; Jun Lan; Hedi Chen; Yuyan Wang; Hongyang Shi; Fei Feng; Da-Yuan Chen; Brianna Close; Xiaomin Zhao; Jianping Wu; Boxue Tian; Zhenghong Yuan; Dongming Zhou; Mohsan Saeed; Xinquan Wang; Rong Zhang; Qiang Ding
Journal:  J Virol       Date:  2021-10-20       Impact factor: 5.103

5.  Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2.

Authors:  Chuan Zeng; Zaijiao Ye; Ling Fu; Yu Ye
Journal:  J Infect       Date:  2021-12-30       Impact factor: 38.637

6.  Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2.

Authors:  Molly Brady; Conor McQuaid; Alexander Solorzano; Angelique Johnson; Abigail Combs; Chethana Venkatraman; Akib Rahman; Hannah Leyva; Wing-Chi Edmund Kwok; Ronald W Wood; Rashid Deane
Journal:  Commun Biol       Date:  2021-11-22

7.  Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain.

Authors:  Cecylia Severin Lupala; Vikash Kumar; Xiao-Dong Su; Chun Wu; Haiguang Liu
Journal:  Comput Biol Med       Date:  2021-11-03       Impact factor: 6.698

8.  ADAM17/MMP inhibition prevents neutrophilia and lung injury in a mouse model of COVID-19.

Authors:  Nathaniel L Lartey; Salvador Valle-Reyes; Hilda Vargas-Robles; Karina E Jiménez-Camacho; Idaira M Guerrero-Fonseca; Ramón Castellanos-Martínez; Armando Montoya-García; Julio García-Cordero; Leticia Cedillo-Barrón; Porfirio Nava; Jessica G Filisola-Villaseñor; Daniela Roa-Velázquez; Dan I Zavala-Vargas; Edgar Morales-Ríos; Citlaltepetl Salinas-Lara; Eduardo Vadillo; Michael Schnoor
Journal:  J Leukoc Biol       Date:  2021-11-26       Impact factor: 6.011

9.  Evidence for a mouse origin of the SARS-CoV-2 Omicron variant.

Authors:  Changshuo Wei; Ke-Jia Shan; Weiguang Wang; Shuya Zhang; Qing Huan; Wenfeng Qian
Journal:  J Genet Genomics       Date:  2021-12-24       Impact factor: 4.275

10.  Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2.

Authors:  Shihui Sun; Hongjing Gu; Lei Cao; Qi Chen; Qing Ye; Guan Yang; Rui-Ting Li; Hang Fan; Yong-Qiang Deng; Xiaopeng Song; Yini Qi; Min Li; Jun Lan; Rui Feng; Yan Guo; Na Zhu; Si Qin; Lei Wang; Yi-Fei Zhang; Chao Zhou; Lingna Zhao; Yuehong Chen; Meng Shen; Yujun Cui; Xiao Yang; Xinquan Wang; Wenjie Tan; Hui Wang; Xiangxi Wang; Cheng-Feng Qin
Journal:  Nat Commun       Date:  2021-09-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.